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Abstract 
Thyroid hormones, thyroxine and triiodothyronine (T3) are crucial for cerebral cortex 
development acting through regulation of gene expression. To define the 
transcriptional program under T3 regulation we have performed RNA-Seq of T3-
treated and untreated primary mouse cerebrocortical cells. The expression of 1,145 
genes or 7.7% of expressed genes was changed upon T3 addition, of which 371 
responded to T3 in the presence of cycloheximide indicating direct transcriptional 
regulation. The results were compared with available transcriptomic datasets of 
defined cellular types. In this way we could identify targets of T3 within genes enriched 
in astrocytes and neurons, in specific layers including the subplate, and in specific 
neurons such as prepronociceptin, cholecystokinin, or cortistatin neurons. The 
subplate and the prepronociceptin neurons appear as potentially major targets of T3 
action. T3 up-regulates mostly genes related to cell membrane events, such as G-
protein signaling, neurotransmission, and ion transport, and down-regulates genes 
involved in nuclear events associated with the M phase of cell cycle, such as 
chromosome organization and segregation. Remarkably the transcriptomic changes 
induced by T3 sustain the transition from fetal to adult patterns of gene expression. 










The thyroid hormones (TH) thyroxine (T4) and 3,5,3triiodo-L-thyronine (T3) exert 
important actions during vertebrate development, for example amphibian 
metamorphosis (Brown and Cai 2007; Denver 2013), and are crucial for mammalian 
brain development (Bernal 2005, 2007).  TH deficiency during maturation alters 
cognitive development and causes profound neurological impairment (Bernal 2015; 
Berbel et al. 2014). An example is the dramatic phenotype caused by mutations of the 
specific TH transporter MCT8 (monocarboxylate transporter 8). MCT8 mutations 
impair T4 and T3 transport through the blood-brain barrier causing the profound 
intellectual deficit and neurological impairment present in Allan-Herndon-Dudley 
syndrome (Bernal et al. 2015). 
Knowledge of the molecular basis of TH action on brain development remains 
fragmentary. In rodents TH deficiency interferes with cerebral and cerebellar cortex 
development in part by impairing the migration and differentiation of neurons. In the 
neocortex TH deprivation impairs radial and tangential migration, and the 
differentiation of many neuronal types, including pyramidal cells and interneurons 
(Berbel et al. 1985, 1996, 2001). Most actions of TH are mediated by the interaction of 
the active hormone T3 with nuclear receptors (TRs). The TRs (TR1, TR1 and TR2)  
are ligand-modulated transcription factors encoded by the THRA and THRB genes 
(Brent 2012; Ortiga-Carvalho et al. 2014). THRA is the predominant TR gene expressed 
in brain. Thra mutations in mice cause behavioral alterations and impair the 
differentiation of interneurons (Venero et al. 2005; Wallis et al. 2008). In humans some 
forms of thyroid hormone resistance due to THRA mutations are associated with 
intellectual deficit (Bochukova et al. 2012).  
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Through the binding to the TRs, T3 modulates gene expression, and the precise 
identification of the gene network under control of T3 in neural cells is needed to 
define the role of thyroid hormones in development. Efforts in this direction have relied 
on in vivo and in vitro approaches. The in vivo approaches face the difficulty that the 
results obtained using paradigms of TH deficiency or administration are variable as a 
function of the brain region and the age taken for analysis making it extremely difficult 
to obtain a global view. For example, Reln, Nrgn, or the myelin genes are under TH 
regulation only during narrow windows of development, or in specific regions of the 
brain (Alvarez-Dolado et al. 1999; Iniguez et al. 1996; Rodriguez-Pena et al. 1993). 
Another difficulty is to distinguish the T3 primary transcriptional responses, from 
secondary and more distal responses, which may be consequences of nonspecific 
effects of hormonal deprivations. Transformed cell lines are useful to dissect molecular 
mechanisms, but do not reflect the physiological situation. All these difficulties have 
been well summarized in a recent review (Chatonnet et al. 2015).  
In this work we have used primary mouse neocortical cells as more representative of in 
vivo situations than established cell lines. Primary cerebrocortical cells were used in 
the past to study the metabolism and action of thyroid hormones (Kolodny et al. 1985; 
Leonard and Larsen 1985; Lorenzo et al. 1995). Through immunofluoresce and RNA-
Seq-based transcriptomic analysis we provide evidence that the primary cells are very 
heterogeneous, maintaining a high phenotypic diversity in the culture. This property 
can be exploited by using available databases of specific cell-type transcriptomes, to 
dissect the actions of T3 on gene expression in discrete cellular populations. Results of 
transcriptomic analyses in the presence and absence of T3, show that the action of T3 
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depends on the expression of its nuclear receptors and that most neural cell types are 
transcriptionally responsive to T3. In addition, about one third of the genes whose 
expression is changed by T3 are regulated by the hormone directly at the 
transcriptional level. T3 mostly up-regulates genes involved in signaling events at the 
plasma membrane and down-regulates genes encoding proteins involved in nuclear 
events related to cell division. Finally the transcriptomic changes induced by T3 
partially overlap with those taking place in the transition from the embryonic to the 
adult cerebral cortex. Overall, our data provide a novel and comprehensive view on 
the function and mechanisms of action of TH on neocortex development and open 
many new avenues for further investigation.  
Materials and methods
An extended description of the methodology is in supplemental Mat & Met. 
Primary cerebrocortical cell cultures 
Protocols for animal handling were approved by the local institutional Animal Care 
Committee, according to European Union rules. Mice of a hybrid genetic background 
of 129/OLa+129/Sv+ BALB/c+C57BL/6 were used (Gil-Ibanez et al. 2013). Primary 
cerebrocortical cultures were established from the whole neocortex of 6 individual 
E17.5 fetuses.  Each fetus originated two identical cell culture replicas, one for T3 
treatment and another as control. The cultures were established in poly-L-ornithine-
coated 12-well plates (Sigma) and incubated for 9 days, with periodic medium changes, 
in NB medium [(Neurobasal Medium (Gibco® Life Technologies) containing 2% B27 
supplement (Gibco®), supplemented with glutamine and antibiotics)]. B27 was 
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removed from the NB medium 24 hours before adding T3 (Sigma) at a final 
concentration of 10 nM. The T3 solution contained a small amount of TH-deprived 
serum for stabilization, and the final concentration of serum in the culture medium 
was 0.1%. Cells were harvested 24 hours later. For the experiments involving 
cycloheximide (CHX, Sigma), CHX was added to the cells at a final concentration of 8 
µg/ml 30 minutes before adding T3 (10 nM), and the cells harvested 6 hours after T3 
addition.  
Inmunofluorescence 
Immunofluorescence was performed on cells plated on glass coverslips fixed with 
absolute acetone and permeabilized with 0.5% Triton X-100. The primary antibodies 
were: mouse monoclonal anti glial fibrillary acidic protein (GFAP) (Clone G-A-5, 1/500 
dilution, Sigma), rabbit polyclonal anti neuronal specific nuclear protein (NeuN, 1/500 
dilution, Millipore, Temecula, CA, USA), mouse monoclonal anti calbindin (D28K 1/500 
dilution, Sigma), mouse monoclonal anti reelin (clone G10 1/500 dilution, Millipore), 
and rabbit polyclonal anti cholecystokinin (CCK-8, 1/100 dilution, Immunostar, Hudson, 
WI, USA). The secondary antibodies were donkey anti mouse Alexa 488 (green), goat 
anti mouse Alexa 488 (green), and donkey anti rabbit Alexa 555 (red) used at 1/500 
dilution. Nuclear staining was with 4,6-diamidino-2-phenylindole (DAPI) (Gibco® Life 
Technologies). Confocal images, acquired using an inverted Zeiss LSM 710 laser 
scanning microscope with a plan-apochromatic objective 63x/N.A 1.3,  were processed 
with Zen 2009 software and Adobe Photoshop. The relative abundance of different cell 
types as a percentage of DAPI-stained nuclei was estimated after counting 100-200 
cells in sextuplicate for each culture in photographs taken using a 40x objective.  
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Transcriptomics 
RNA-Seq was performed at the Genomics Unit of the Centro Nacional de 
Investigaciones Cardiovasculares (CNIC), Madrid. 500 ng of total RNA were used with 
the TruSeq RNA Sample Preparation v2 Kit (Illumina, San Diego, CA) to construct index-
tagged cDNA libraries. Single reads of 75 base length using the TruSeq SBS Kit v5 
(Illumina) were generated on the Genome Analyzer IIx following the standard RNA 
sequencing protocol. Reads were further processed using the CASAVA package 
(Illumina). 
The fasta file containing sequences of this genome was downloaded from Ensembl 
(http://www.ensembl.org/Mus_musculus/Info/Index). This genome was indexed from 
Bowtie (Langmead et al. 2009) and sequence reads were aligned using TopHat 
(Trapnell et al. 2009). We quantified reads to specific genes and transcripts using the 
Python module HT-SEQ (Anders et al. 2015). Read and mapping data quality was 
determined with the application FastQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and Qualimap (Garcia-
Alcalde et al. 2012). We explored gene expression data by Principal Component 
Analysis and Clustering methods. Exploratory analysis was performed using the 
Bioconductor package NOISeq (Tarazona et al. 2011) (supplemental Mat & Met, RNA-
Seq quality controls). RNA-Seq data were normalized using Trimmed Mean of M values 
(Robinson and Oshlack 2010). The paired design was analyzed from the Bioconductor 
package edge R (Robinson et al. 2010), fitting a Negative Binomial Generalized Linear 
Model. Conventional multiple testing p-value correction procedure proposed by 
Benjamini-Hockberg was used to derive adjusted p-values (Benjamini and Hochberg 
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1995). Length of genes and transcripts was estimated from only coding regions. 
Expression levels were estimated using the RPKM method (reads per kilobase of 
transcript per million mapped reads). The RNA-Seq data have been deposited in the 
National Center for Biotechnology Information (NCBI) Gene Expression Omnibus (GEO) 
and is accessible through GEO Series accession number GSE68949 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68949). 
Enrichment analysis was carried out for the Gene Ontology terms using the 
Bioconductor package GOSeq (Young et al. 2010). GO enrichment was estimated 
compared to the genes expressed in the presently cultured cells. We corrected for 
multiple testing by Benjamini-Hochberg procedure. Significant Gene Ontology terms 
were represented from CellMaps (http://cellmaps.babelomics.org/).  
Quantitative PCR assays were performed were performed using standard procedures 
(Supplemental Mat & Met) on TaqMan low-density arrays (Applied Biosystems) format 
48a (P/N 4342253). Data were corrected for 18S RNA and expressed relative to the 
values obtained for the control cells without T3.  
Results 
Cellular and molecular characterization of the primary cultures 
The purpose of this study was to obtain a global view on the role of thyroid hormone on 
neocortex development, through identification of the regulated genes. This was done 
by transcriptomic analysis of T3 action in primary cultures of cerebrocortical cells. 
10 
Primary cell cultures were established from E17.5 whole mouse cortices. 
Characterization of the primary cultures with specific antibodies revealed the presence 
of astrocytes (15%) and neurons (75%), and specific neuronal phenotypes as shown by 
immunofluorescence for cholecystokinin and for two known T3-dependent proteins, 
calbindin and reelin (Supplemental fig 1), expressed by less than 5-10% of the neurons. 
Phenotypic diversity was further confirmed by the RNA-Seq data, which showed 
expression of markers for different cerebral cortex layers and neuronal types.  
RNA-Seq data analysis showed that 14,801 genes were expressed in the culture. From 
this set we identified the genes encoding proteins involved in T3 action in the brain, 
such as membrane transporters, deiodinases, and nuclear receptors and coregulators 
(Supplemental fig 1). The major TH transporter expressed was Slc16a2 (Mct8), followed 
by Slco3a1 (Oatp3a1), Slc7a5 (Lat1), Slco1c1 (Oatp1c1), and Slc7a8 (Lat2). Very low 
expression levels were found for Slc16a10 (Mct10), a transporter expressed in 
microglia, and Slco1a4 (Oatp1a4), highly expressed in endothelial cells (Bernal et al.
2015). As for the receptors, the mRNAs for the T3-binding products of the Thra and 
Thrb genes (Thra1 and Thrb) were expressed in similar amounts, whereas the non-T3 
binding splicing product of the Thra gene, Thra2 mRNA was present at a concentration 
30-fold higher than Thra1 or Thrb. Finally the deiodinases Dio2 and Dio3 and the 
coregulators Ncor1 corepressor and Ncoa1/Src1 coactivator mRNAs were also present. 
Accordingly the primary cells were responsive to T3, as shown by the 2-6 fold increased 
expression after T3 of the known T3 targets Camk4, Dio3, and Hr (Supplemental fig 1).  
Transcriptomic changes induced by T3 
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After incubation with 10 nM T3 for 24 hours, the number of differentially expressed 
(DE) genes, in comparison to cells in the absence of T3 was 1,145 (false discovery rate 
<0.05) (Fig 1A and supplemental table 1). From these, 619 were up regulated, and 526 
down regulated by T3. We refer to these genes as positive and negative genes, 
respectively. Among the positive genes with the most significant changes after T3 
treatment we identified genes well known to be regulated by T3 in vivo (Chatonnet et 
al. 2015), such as Hr, Shh, Kcnj10, Flywch2, Sema3c, Klf9, Rasd2, and Dio3. Within the 
list of negative genes, two known T3 down-regulated genes, Calb1 and Aldh1a3 were 
present. Validation of gene expression changes was performed by qPCR in biological 
replicates using RNA from independent cultures. Fig 1B shows the relative expression of 
24 positive genes and 6 negative genes in the T3-treated cells compared to the 
untreated cells. There was a good correlation between the results obtained by RNA-Seq 
and qPCR (Fig 1C).  
Direct responses to T3 
To proof that the T3-induced transcriptomic changes required the presence of the TRs 
we performed RNA-Seq of cerebrocortical cells isolated from Thra1-/-Thrb-/- mice (Gil-
Ibanez et al. 2013) similarly treated or untreated with T3. No significant changes of 
gene expression after T3 were found (Supplemental table 1), indicating that the 
transcriptomic changes induced by T3 in the wild type cells were mediated exclusively 
through interaction with the nuclear receptors. 
Then we proceeded to the identification of the DE genes that were direct 
transcriptional responses to T3 i.e., not mediated by changes in the expression or 
activity of other proteins that might influence the transcription or the half-life of the 
Fig 1 
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target mRNAs. To this end we used the protein translation inhibitor CHX to identify 
what genes within the 1,145 differentially expressed genes at 24 hours were still 
induced or repressed 6 hours after T3 addition in the presence of CHX. We previously 
used this approach successfully to determine that Hr, Klf9, Shh, and Aldh1a3 were 
direct transcriptional responses to T3 in similar primary cultures (Gil-Ibanez et al.
2014). RNA-Seq was performed to compare cells treated with T3 for 6 hours in absence 
of CHX, with cells treated with T3 in the presence of CHX, and compared with the 
effect of T3 at 24 h. 
As shown in Fig 2A, from the set of 1,145 genes regulated by T3 at 24 hours (619 
positive and 526 negative), 562 responded to T3 at 6 hours (336 positive and 226 
negative). From this set, 371 genes responded to T3 in the presence of CHX (254 
positive and 117 negative; supplemental tables 1 and 2). As shown in supplemental 
table 2, the genes regulated directly by T3 encode proteins that can be classified into 
diverse functional groups, especially transcription factors, G proteins, cell adhesion 
and extracellular matrix proteins and membrane transporters. We crossed our data 
with the chromatin immunoprecipitation data of Chatonnet et al. (2013) and found 
that a fraction of this set, 106 genes (89 positive, and 17 negative genes), contain 
proximal TR binding sites (TR binding sites located within 30Kb of a T3-regulated gene). 
Among the directly regulated genes were Hr, Dbp, Klf9, and Gbp3 (distal binding site) 
considered by Chatonnet et al (2013) as the genes with the most conclusive evidence 
for direct T3 regulation.  
Within the negative genes we found Mc4r, encoding the type 4 melanocortin receptor, 
also demonstrated as transcriptionally regulated by T3 through a negative T3 
Fig 2 
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responsive element (Decherf et al. 2010). Individual responses of the 562 genes 
responding to T3 at 6 and 24 hours were used to construct a heatmap plot (Fig 2C) 
revealing different patterns of response. The most significant are illustrated in Fig 2D 
with individual examples. In the set of positive genes, the response to T3 at 6 hours 
could be lower (Flywch2, Sema6c, Olfm4), equal (Klf9, Slc22a3), or higher (Bcl2l11) 
than at 24 hours, defining different time-courses of response. In the presence of CHX, 
T3 had the same (Flywch2) or higher effect (Klf9, Sema6c, Bcl2l11) than in its absence, 
or no effect (Olfm4, Slc22a3). This means that Flywch2, Klf9, Bcl2l11, and Sema6c were 
direct responses to T3, and that Klf9, Bcl2l11, and Sema6c mRNAs were in addition 
stabilized by CHX. Olfm4 and Slc22a3 were secondary responses. For the negative 
genes, the effect at 6 h could be lower (Ntf3, Dcn) equal (Egflam) or higher (Syt17) 
than at 24 hours. In the presence of CHX, T3 at 6 hours had the same (Ntf3), or lower 
effect (Syt17) than in its absence, or no effect at all (Egflam, Dcn). These patterns can 
be interpreted as explained for the positive genes. 
Transcriptomic changes induced by T3 in specific cell types 
The primary cultures contained a heterogeneous diversity of cellular phenotypes. We 
took advantage of this property of the culture to identify the cell types expressing 
genes directly responsive to T3. First, we analyzed the relative contributions of 
astrocytes and neurons to the transcriptomic T3 response. To this end we compared 
our data set with a transcriptome database of acutely purified astrocytes and neurons 
of postnatal mice (Cahoy et al. 2008) to determine to what extent genes of enriched 
expression in astrocytes or neurons were regulated by T3 (Fig 2B). Setting a lower limit 
of 5-fold expression in astrocytes or in neurons to consider a gene enriched in a given 
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cell type, a total of 137 T3-regulated genes were enriched in neurons and 76 in 
astrocytes (Table 1). Even some neuron or astrocyte specific genes, i.e., those with 
more than 40-fold enrichment were regulated by T3 (Supplemental table 3). Of the 
137 neuron-enriched genes 62 were regulated directly by T3, and of the 76 astrocyte-
enriched genes 20 were directly regulated (Fig 2B and Table 1). The results indicate 
that neurons and astrocytes are direct cellular targets of T3 at the genomic level. 
Astrocytes were proposed as mediators of many effects of TH on brain structure and 
function through the control of cytoskeletal proteins, growth factors and cell adhesion 
molecules (Dezonne et al. 2015). Up to 23 genes encoding extracellular matrix proteins 
and adhesion molecules enriched in astrocytes were regulated by T3 in our cultures. 
Among the genes previously proposed as T3 targets, we found the heparan sulphate 
proteoglycans Gpc6, directly regulated, and Sdc4, indirectly regulated. 
To identify specific neuronal types as T3 targets we followed a similar approach. We 
compared our data set with a transcriptome database of cerebral cortex cell types 
isolated using the translating ribosome affinity purification (TRAP) approach (Doyle et 
al. 2008). This study provides the translational profiles of many cell types of the CNS, 
and is an excellent resource to identify cell-enriched mRNAs. Table 1 shows the 
number of genes enriched in neurons from different cortex layers or expressing 
specific markers, their representation in the culture, and the number of T3 regulated 
genes. We found that around 50% of genes enriched in specific neurons were 
expressed in the culture. From these, between 7.1% (for cholecystokinin, CCK neurons) 
and 24% (for prepronociceptin, PNOC neurons) were regulated by T3. As for the 
directly regulated genes the proportion ranged between 2.1 % of the enriched genes in 
Table 1 
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the CCK neurons, and 12.1% in PNOC neurons, identifying this population of cells as a 
major cellular target of TH. 
Subplate neurons have a crucial role in the maturation of cortical intrinsic and extrinsic 
circuits (Hoerder-Suabedissen and Molnar 2015). As shown also in table 1, a high 
proportion (94%) of subplate-enriched genes (Hoerder-Suabedissen et al. 2013) was 
expressed in the culture, and 20% of them (82 genes) was regulated by T3. From these 
35 were regulated directly. Furthermore, 68 subplate genes have been described as 
being subplate-specific at any one time (Hoerder-Suabedissen et al. 2013). As shown in 
supplemental table 4, 23 of the subplate-specific genes were under T3 regulation, 8 of 
them in a direct fashion.  Remarkably T3 negatively regulates genes of early embryonic 
expression and positively regulates genes of postnatal expression. 
Gene Ontology analysis 
Gene ontology enrichment analysis was performed in two ways. On the one hand we 
included in a single set the 1,145 differentially expressed genes. In addition we 
separated the up-regulated and the down-regulated genes in two sets for independent 
analysis. All the significant GO terms (with Padjust < 0.05) and genes included in the 
analysis are detailed in supplemental table 5 and supplemental figure 2. From the set 
combining all the differentially expressed genes the functions represented included 
response to stimulus and signal transduction, especially processes related to G-protein 
coupled receptor activity, regulation of nervous system development, cell 




Some of the enriched GO terms were specifically represented in one of the sets of 
positively or negatively regulated genes. For better visualization of the data, the most 
representative terms for Molecular Function, Biological Processes and Cellular 
Component domains are summarized in Fig 3A for the up-regulated and Fig 3B for the 
down-regulated genes. T3 specifically upregulates genes involved in transmission of 
the nerve impulse, processes involving ion transport, (i.e. anion-cation symporter 
activity, sodium ion transmembrane transport), ephrin receptor activity, cell adhesion 
and chemotaxis (Supplemental table 5). Among the genes up-regulated by T3 are also 
genes involved in myelin assembly and in protein localization at the paranodal region. 
The genes negatively regulated by T3 are specifically enriched in cell division, 
particularly in chromosome segregation and organization during the M Phase of cell 
cycle. Regulation of chemokine-mediated signaling pathway is also highly represented. 
Genes involved in neurogenesis, and in neuron differentiation are represented in both 
gene sets, but astrocyte differentiation is specifically induced by T3.  
Within  the Cellular Component domain, T3 induces mainly transmembrane and axonal 
proteins, neurofilaments, and extracellular proteins, and specifically down regulates 
nuclear proteins related to the condensed chromosome and the MCM complex, and 
genes encoding proteins of the motile cilium. 
It was also of interest to perform GO analysis of the genes directly responsive to T3 at 
6 h in the presence of CHX. The full data are given in supplemental table 6, and a 
summary with the most enriched GO terms within the Molecular Function domain is in 
table 2. In general the terms enriched were similar to those obtained when the 24-
hour gene set was analyzed, with the top definitions represented by transmembrane 
Fig 3 
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signal transduction processes, especially those involving G proteins. Molecular function 
terms involving ephrin signaling were also significantly represented. 
Comparison with in vivo studies 
To extrapolate the identified cellular T3 target genes to in vivo regulation we 
compared the differentially expressed genes in the primary cells with previous data 
sets from rat and mouse cerebral cortex hypothyroidism during the fetal (Morte et al. 
2010a; Dong et al. 2014) and postnatal periods (Morte  et al. 2010b). From these 
comparisons, shown in Supplemental table 7, we can conclude that around 20% of the 
brain genes altered in expression by fetal and postnatal hypothyroidism in vivo, are 
real cellular targets of T3 and not altered as a distal effect of hypothyroidism. The 
overlapping list of 329 T3-regulated genes represents a valuable data set to break 
through the genomic targets of TH involved in brain development.  
T3 favors an adult versus embryonic profile of gene expression 
The transition between the embryonic and adult brain involves substantial changes in 
the expression of genes related to developmental processes. Dillman et al. (2013) 
performed comparisons of transcriptome profiles between these two stages and 
defined a set of 1,185 genes highly expressed (fivefold or greater) in the embryonic 
versus the adult cerebral cortex and another set of 2,943 genes enriched in the adult 
compared to the embryonic cortex. Given the importance of TH in brain maturation, it 
was of interest to analyze whether T3 was involved in the relative expression of these 
two gene sets in the primary cultures. For this reason we analyzed the overlap 
between our gene expression data set and the over-represented embryonic and adult 
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transcriptomes. From the total of 14,801 genes expressed in the primary cells, 
approximately half of the 5X embryonic (649 genes) and of the adult gene sets (1,563 
genes) were present (Table 3).  Sixteen percent (107 of 649) of the genes enriched in 
the embryonic cortex were negatively regulated by T3, in contrast to only 4% (67 of 
1,563) of the adult cortex enriched genes. Conversely, T3 positively regulated 12% (196 
of 1,563) of the adult cortex genes versus 3% (22 of 649) of the embryonic genes.  
Discussion 
Efforts to identify the gene network regulated by T3 during brain development have 
given only fragmentary information, highly depending on the region of the brain, 
developmental stage, and compounding factors of in vivo studies.  We here have 
employed RNA-Seq to analyze the transcriptomic changes induced by T3 in mouse 
primary cerebrocortical cells in culture. These cells are a very heterogeneous mix of 
cells with an extraordinary diversity of cell phenotypes, as confirmed by 
immunofluorescence and by the outcome of the transcriptomic analysis.  We believe 
that these cultures allow obtaining a global view of T3 action on the different cell types 
of the neocortex. The T3-dependent patterns of expression may then be extrapolated 
to in vivo development to define the potentiality of T3 action on neocortex 
development, at least at the cellular level (Gil-Ibanez et al. 2014).  
Not surprisingly T3 had a large effect on the transcriptome of the primary cells. The 
expression of 1,145 genes (7.7% of expressed genes) was modified 24 hours after 
exposure to T3. The response to T3 was mediated through the TRs, as no effect was 
found in cells from TR null mice. Furthermore, 32% of these genes were directly 
regulated by the hormone at the transcriptional level.  The full list of regulated genes 
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presented in the supplemental tables have a great and powerful heuristic value to 
identify the molecular basis of TH action on developmental processes known to be 
affected by these hormones, and to discover new processes so far unsuspected as 
being under the influence of thyroid hormones (Berbel et al. 2014). Some of the T3-
regulated pathways profoundly influence developmental processes, for example the 
sonic hedgehog pathway. Among the genes with a more robust transcriptional 
induction by T3 was Shh, a gene previously known to be regulated by T3 in the mouse 
brain in vivo and in cortical cells (Desouza et al. 2011). Regulation of this gene by T3 
likely influences many biochemical processes in the developing and adult brain (Ho and 
Scott 2002; Alvarez-Buylla and Ihrie 2014). A challenge for future work is the 
clarification of the specific role of T3 on developmental processes acting through Shh
expression, beyond the local regulation of deiodinase activity (Dentice 2011). 
The GO analysis led to the surprising conclusion that T3 preferentially up-regulates 
genes involved in signaling at the plasma membrane and down-regulates genes 
encoding nuclear proteins associated with cell division.  Cerebellar, but not cerebral 
hemispheres astrocytes are stimulated to proliferate by T3. But this shown as a 
delayed and indirect effect due to stimulation of secretion of astrocytic growth factors 
(Trentin et al. 1995). Most actions of T3 are related to migration or differentiation. A 
crucial process of cortical development is the migration of postmitotic neurons from 
the proliferative zones to form the cortex layers (Rakic 1990). Among the most 
relevant actions of T3 on the developing neocortex is the control of cell migration. 
Transient maternal hypothyroxinemia at onset of corticogenesis alters radial and 
tangential migration of neurons (Lavado-Autric et al. 2003; Auso et al. 2004; Cuevas et 
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al. 2005). Given the age at which the cultures were established, the effects of T3 on 
genes involved in migration will likely affect the neuronal migration to layers 2/3, 
especially radial distribution of callosal projecting neurons and subsequently their 
connectional pattern (Lucio et al. 1997). In agreement with these in vivo effects of 
thyroid hormones, up to 17 cell-adhesion molecules and 25 extracellular matrix 
proteins were regulated directly by T3 in the primary cultures. Many of the 
differentially expressed genes are involved in the tangential migration of GABAergic 
interneurons from the medial ganglionic eminence. These include genes encoding 
transcription factors implicated in interneuron development (Mafb, Etv1, Npas1); 
receptors regulating migration such as ErbB4, and Cxcr7 and its ligand Cxcl12, 
chemorepulsive molecules (Slit2, Slit3, Robo1, Robo2, EphrinA5 and EphA4), as well as 
Sema3a and its receptor Nrp1 that are important to maintain the interneuron 
migrating route. Many of the encoding genes are under direct transcriptional control 
by T3, such as Mafb and Robo2, Etv1, Slit2, Sema3a, and Nrp1.  
The inside-out pattern of radial migration during corticogenesis is critically controlled 
by the extracellular matrix protein reelin produced by the Cajal-Retzius neurons (Rice 
and Curran 2001). In rats hypothyroidism alters the expression of Reln transiently 
during the perinatal period (Alvarez-Dolado et al. 1999). Here we find that Reln was 
not a primary, but a secondary response to T3. Transcription factors regulating the 
Reln promoter, Sp1, Pax6, and Tbr1 (Grayson et al. 2006) were not regulated by T3 in 
our study. However, the transcription factor Emx1, important for the production of 
Cajal-Retzius cells and subplate neurons (Shinozaki et al. 2002) was regulated directly 
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by T3. Therefore, T3 might control the expression of the Reln gene by facilitating the 
generation or differentiation of the Cajal-Retzius cells.  
Related to the above discussion we found that a large fraction of subplate enriched 
and specific genes were regulated by T3, and many of them directly at the 
transcriptional level. We believe that this is an important finding, given the role of the 
subplate in the organization of intracortical and thalamocortical circuitry, and in 
tangential migration of interneurons (Hoerder-Suabedissen and Molnar 2015). A direct 
action of T3 on subplate maturation may underlie the effects of hypothyroidism on 
disruption of cortical circuitry and the formation of cortical maps and could be of 
relevance in the etiology of autism (Berbel et al. 2014). Actually the subplate-specific 
genes Cdh18, Gabra5, and Prss12 and the subplate-enriched genes Sema5a and Cdh10, 
all regulated by T3, have been linked to autism (Hoerder-Suabedissen et al. 2013).  
Slc1a2, which contains a TR binding site (Chatonnet et al. 2013) has been linked to 
schizophrenia (Hoerder-Suabedissen et al. 2013).  
About two thirds of the DE genes were not direct transcriptional responses to T3. 
Regulation of these genes might be secondary to a primary effect of T3 on the 
expression of transcription factors or components of signaling cascades. Among the DE 
genes we found 101 transcription factors or transcriptional cofactors and coregulators, 
of which 48 were directly regulated by T3. Within this category it is worth mentioning 
Klf9, a transcription factor already known to be under TH control in many cell types 
(Hoopfer et al. 2002; Martel et al. 2002; Denver and Williamson 2009; Dong et al.
2014; Scobie et al. 2009; Dugas et al. 2012; Avci et al. 2012). Other transcription 
factors are novel transcriptional targets of T3, and mediate an array of important 
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actions on neural cells, including survival (Tox3, Klf6) (Dittmer et al. 2011; Salma and 
McDermott 2012), neuronal differentiation and specification (Satb, Bhlhb5, Nr4a3, 
Zbtb20, Emx1) (Britanova et al. 2008; Joshi et al. 2008; Cocas et al. 2009; Xie et al. 
2010; Eells et al. 2012), progenitor cell division (Mycn, Emx1) and maintenance (Zhx2). 
Emx1 is important for Cajal-Retzius cells and the subplate as mentioned above, and 
Mycn is involved in differentiation of radial glial precursors (Zinin et al. 2014). The 
circadian oscillator Dbp is known as a T3-dependent transcription factor in several 
animal models (Chatonnet F et al. 2015). In this study we also obtained Dbp as a DE, 
directly regulated gene. Interestingly, another transcription factor, Nfil3, directly 
regulated by T3, cooperates with Dbp in determining the length of the circadian 
oscillator (Yamajuku et al. 2011). 
The primary culture data set allows drawing conclusions on T3 action in specific 
cellular types by comparing the data with transcriptomic databases of different cell 
types (Cahoy et al. 2008; Doyle et al. 2008). We found that T3 exerts direct 
transcriptional regulation in astrocytes and in neurons. In astrocytes, we identify direct 
targets among genes involved in neuron migration and differentiation, such as the 
heparan sulfate proteoglycan gene Gpc6. Remarkably all the neuronal types analyzed 
are direct transcriptional targets of T3, in agreement with TR1 expression in 
practically all neurons (Wallis et al. 2010). The relatively high number of DE genes 
enriched in different cell types indicates a prominent role of TH in the maintenance of 
most cellular phenotypes. The Pnoc neurons (Doyle et al. 2008) appear as unique T3 
target cells given the relatively high number of directly regulated genes. Other known 
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cell targets of T3, the oligodendrocytes and the Parvalbumin-expressing interneurons, 
were not present in the culture, given their postnatal appearance during development.  
The partial overlap between the gene network involved in the transition from the 
embryonic to adult brain and the T3 regulated genes suggests a formulation for the 
biological role of thyroid hormones during development. The embryonic brain is 
enriched in genes included in the GO categories of cell division, M phase of cell cycle, 
and chromosome segregation and organization, whereas the mature nervous system is 
enriched in genes involved in neurotransmission and ion transport (Dillman et al. 
2013). The GO categories more highly represented in the set of genes down regulated 
by T3 in the primary cells highly overlap with the enriched functions in the embryonic 
brain. Conversely the categories more represented in the set of up regulated genes 
overlap with the enriched functions of the mature brain. Therefore regulation of gene 
expression during development of the nervous system by TH facilitates the transition 
from the embryonic to the mature brain. The same conclusion can be drawn from the 
effects of T3 on the subplate-specific genes. 
In summary, T3 regulates many signaling pathways during cerebral cortex 
development through the control of the expression of many different classes of genes. 
A large fraction of these genes are direct transcriptional targets of T3, involved in 
cerebral cortex development. Remarkably T3 preferentially up regulates genes 
involved in signaling pathways at the cell plasma membrane, and down regulates 
genes involved in nuclear events associated to cell division. By doing so T3 is a critical 
factor in processes of neuron migration, axon elongation, and synaptogenesis and 
promotes the transition from the embryonic to adult pattern of gene expression. In 
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this work we identify many genes involved in T3 action and differentiate between 
primary and secondary transcriptional targets of T3. The databases accompanying this 
paper will be a most valuable resource to address the involvement of T3 in specific 
signaling pathways and cellular fates, and provide a starting point to understand the 
role of T3 in neural disorders. 
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 (% of 
expresse
d genes) 
Mixed culture 14.801 1.145 7.7 371 2.5 
Neurons 719 569 137 24.2 62 10.8 
Astrocytes 480 380 76 20.0 20 5.2 
Corticothalam
icLayer 6 594 333 43 1.9 15 4.5 
Corticospinal 
Layer 5b 1,177 662 59 8.9 18 2.7 
Corticostriatal 
Layer 5a 3,695 1,823 168 9.2 54 3.0 
CCK  
neurons 571 240 17 7.1 5 2.1 
Cortistatin 
neurons 482 232 30 12.9 10 4.3 
Pnoc 
neurons 114 58 14 24.1 7 12.1 
Subplate 418 394 82 20.8 35 8.8 
Data on cell-type enriched genes in astrocytes and neurons were from Cahoy at al. 
(2008). Genes enriched in layers 6, 5b, and 5a, and the CCK, cortistatin and pnoc 
neurons were from Doyle et al. (2008). The subplate data were from Hoerder-
Suabedissen et al. (2013).  
37 
Table 2: Gene Ontology Molecular Function categories enriched in the set of genes directly 
regulated by T3 
GO description adjusted_pvalue N genes DE in GO 
N genes 
in GO perc_enrichement 





4.68E-09 41 380 0.10789 















0.00051 21 203 0.10345 
GO:0005102 receptor binding 0.00136 43 794 0.05416 
GO:0005003 ephrin receptor activity 0.00615 5 13 0.38462 
GO:0005515 protein binding 0.00778 167 4940 0.03381 






0.02102 8 48 0.16667 
GO:0042562 hormone binding 0.02818 7 49 0.14286 










0.04895 7 46 0.15217 
This table shows: the Gene Ontology (GO) term and description; the adjusted P value; 
the number (N) of genes differentially expressed (DE) contained in each of the GO 
definitions; the total number of genes present in the GO definitions; and the percent 
enrichment of DE within each definition. 
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Table 3. Regulation by T3 of genes enriched in the embryonic and adult cerebral cortex 












Embryonic 1,185 649 Up:        22 Down:  107 
Up:        3% 
Down: 16% 
Adult 2,943 1,563 Up:     196 Down:   67 
Up:     12% 
Down:  4% 
Genes enriched at least 5X in the embryonic mouse cerebral cortex with respect to the adult 
cerebral cortex, and viceversa were taken from (Dillman et al. 2013). 
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Caption to figures 
Figure 1: A. Volcano plot of RNA-Seq of cells treated with T3 for 24 h and untreated 
cells. Scattered points represent individual genes. The X-axis is the log2 of the fold 
change between T3 and untreated cells. The Y-axis is the negative log10 of adjusted P-
value (Padjust). Given the wide values for the Padjust-value, the right panel is a blow up of 
the region below 25 (-log10Padjust). Green and blue (log2 of the fold change >1) dots 
represent genes with significant changes in expression (Padjust < 0.05). Red dots 
represent non-significant changes (Padjust > 0.05). The position of selected genes in the 
plot is illustrated with the gene symbols. B. qRTPCR validation of RNA-Seq results in a 
biological replicate. Results are expressed as mean ± SEM relative to the control, 
assigned an arbitrary value of 1.0 and represented by the horizontal dotted line. The 
number of individual samples in all determinations was = 5. Statistical significance was 
calculated by the Students t test. * P < 0.05; * P < 0.01; * P < 0.001. C. Biological and 
technical correlation of the data of gene expression changes for 30 individual genes. In 
the abscissa the data on RNA-Seq measurements of gene expression in T3-treated 
cultures over untreated cultures expressed as the Log2 of fold changes. In the ordinate 
the qRT-PCR data obtained for gene expression of the same genes in different cultures 
similarly treated. 18S RNA was used for normalization. The log2 of fold changes showed 
a positive correlation between the RNA-Seq and the RT-PCR (Pearson r = 0.908, 
P<0.0001)  
Figure 2. A. From up to down: Number of up-regulated (positive) and down-regulated 
(negative) genes after addition of T3 (10 nM) to primary cerebrocortical cultures after 
24. Number of genes up- or down-regulated at 24 and 6 h after T3. Directly regulated 
40 
genes are genes with increased or decreased expression 6 h after T3 in the presence of 
cycloheximide (CHX). Number of genes containing a thyroid hormone receptor (TR) 
binding site, as reported by Chatonnet et al (2013). B. Venn diagram representing the 
overlap between differentially expressed (DE) genes at 24 h, the directly regulated 
genes, and the 5X-enriched genes in neurons and in astrocytes expressed in the 
culture. C. Heatmap representing changes of gene expression induced by T3 at 24 h, 6 
h, and 6 h in the presence of CHX. D. Examples of different gene expression patterns: 
Fold change after 24 h (light grey), 6 h (dark grey) and 6 h in the presence of CHX 
(dark).  Differences were statistically significant (P<0.05) except when indicated (ns = 
not significant).  
Figure 3. Selected Gene Ontology categories significantly over represented (p < 0.05) 
for the positive (3A) or the negative genes (3B). The color gradient, from yellow to red, 
represents the degree of significance of the categories by hypergeometric test with 
Benjamini Hochberg FDR correction. The circle size represents the level of enrichment 
of the categories. Specific GO terms significantly represented either in the set of up-




Supplemental Materials and Methods: Methods for primary cerebrocortical cultures, 
immunoflurescence, Illumina sequencing and RNA-Seq quality controls.
Supplemental Figure 1. Characterization of primary cerebrocortical cells in culture. A-
D, Confocal microscopy after staining the nuclei with DAPI (blue), and with antibodies 
against A: glial fibrillary acidic protein (green) NeuN (red); B: calbindin (green) and 
NeuN (red); C: reelin (green); D: cholecystokinin (green). In all cases the scale bar = 25 
m. E. Expression of genes encoding proteins involved in TH transport (Slc) deiodinases 
(Dio), nuclear thyroid hormone receptor coregulators (Nco), and TH receptors (Thr). 
Data are as RNA reads per kb of transcript per million mapped reads (RPKM). F. Gene 
expression responsiveness of the primary cells 24 h after addition of 10 nM T3, as 
measured by qPCR. Significance of differences was calculated by the Students t -test; 
***p = 0.001.  
Supplemental figure 2: Enriched GO terms in the T3-treated cultures represented 
using GO graphs for a better visualization of the data. Green nodes are significant 
functional terms associated to differentially expressed genes. The uncolored GOs are 
displayed to better represent the relationship between all GOs. 
Supplemental table 1: List of genes regulated by T3 in primary cerebrocortical 
cultures. Included are three groups of data. Group 1: Effect of T3 after 24 hours of 
addition to the culture on gene expression with a false discovery rate (FDR) < 0.05. The 
columns, from left to right show: A) the Ensembl ID; B) the associated gene name; C) 
log2 fold change; D) logCPM (counts per million); E) LR (Likelihood ratio) ; F) P-value ; 
G) FDR; H) Reads Per Kilobase of transcript per Million mapped reads (RPKM) as the 
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mean of all untreated cultures; I) Length of mRNA . Group 2: Effect of T3 on the 
expression of group 1 genes after 6 hours in the absence (columns L-P) and in the 
presence of cycloheximide (CHX) (columns Q-U). Group 3: Lack of effect of T3 on group 
1 genes after 24 hours in primary cultures derived from Thra1-/-Thrb-/- mice (columns 
X-AB). Gene names in red bold are directly regulated genes, i.e., FDR < 0.05 in the 
presence of CHX. *Directly regulated genes containg a thyroid hormone receptor 
binding site (Chatonnet  et al. 2013). 
Supplemental table 2: Genes regulated directly by T3, grouped by gene function.  
Supplemental table 3: T3 effect on gene expression in 5-fold enriched genes of 
astrocytes and neurons. The data included are: enrichment factor in untreated cells; 
log2(fold change) after T3 treatment; RPKM (Reads Per Kilobase of transcript per 
Million mapped reads) in untreated cells as a measure of the basal expression level. 
Genes are ordered by enrichment in neurons or astrocytes. Gene names in red bold 
are directly regulated genes. *Directly regulated genes containing a thyroid hormone 
receptor binding site (Chatonnet et al. 2013). 
Supplemental table 4: Subplate-specific genes regulated by T3.  Indicated in the table 
are the direction of regulation, positive or negative, and the mechanism of regulation, 
directly at the transcriptional level, or indirectly by posttranscriptional mechanisms.  
The gene list was taken from  Hoerder-Suabedissen et al (2013).  
Supplemental table 5: Significantly enriched Gene Ontology categories (MF, Molecular 
Function; BP, Biological Process; CC, Cellular Component) in the T3-treated cultures 24 
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h. GO analysis was performed independently using all the differentially expressed 
genes,the positively regulated genes, and the negatively regulated genes.  
Supplemental table 6: Significantly enriched Gene Ontology categories (MF, Molecular 
Function; BP, Biological Process; CC, Cellular Component) in the set of T3 directly 
regulated genes. 
Supplemental table 7: Overlap between the differentially expressed genes identified in 
primary mouse cerebrocortical cells after T3 induction and the differentially expressed 
genes in cerebral cortex in vivo in the rat fetus (Morte et al. 2010) and the postnatal 
mouse (Morte et al. 2010) under conditions of thyroid hormone deprivation. 
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